New immune cell therapy combo aims to fight tough head & neck cancers
Disease control
Recruiting now
This study is testing whether a combination of three treatments—a modified immune cell infusion, an immune-stimulating protein, and an approved targeted antibody—is safe and effective for people with advanced head and neck cancer that has returned or spread. It is for patients wh…
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC